Get Multiple Myeloma Drugs Market INFOGRAPHICS 2019: The Approval Of New Drugs To Drive The Multiple Myeloma Drugs Market

The global Multiple Myeloma Drugs Market was valued at US$ XX Mn in the year 2018 and is expected to reach US$ XX Mn by the year 2026, growing at a CAGR of 11.8%.

FREMONT, United States - May 22, 2019 /MarketersMedia/ —

Industrial Analysis of Multiple Myeloma Drugs Market
Multiple myeloma is a type of blood cancer that forms in plasma cells. Plasma cells are an important part of a person’s immune system, as they make antibodies that help fight infections.

Multiple myeloma is the second most common haematological cancer. In the year 2016, there were about 130,000 cases of multiple myeloma globally. In the same year, approximately 98,000 deaths were caused by multiple myeloma. The incidence of multiple myeloma is increasing across the globe.

Get Sample INFOGRAPHICS of Multiple Myeloma Drugs Market Report:
https://www.alltheresearch.com/sample-request/107

One of the major factors to drive the growth of the multiple myeloma drugs market is the approval of new drugs for the treatment of this type of cancer. For instance, in March 2019, the National Institute for Health and Care Excellence (NICE) approved Daratumumab in combination with bortezomib and dexamethasone, for the treatment of multiple myeloma. In 2016, the U.S. FDA approved the use of daratumumab in combination with dexamethasone and lenalidomide, or dexamethasone and bortezomib, for multiple myeloma patients who have received at least one prior therapy.
In Feb 2019, Sanofi, another leading pharmaceutical company, has declared the results of Phase III studies for its anti-CD38 therapy, isatuximab. The results revealed that the drug candidate helped in extending progression-free survival in patients with multiple myeloma.

However, most of the drugs used for the treatment of multiple myeloma are nearing patent-expiry. For instance, Celgene Corporation’s Revlimid is slated to lose its patent exclusivity at the end 2019. The looming threat of patent expiry of these drugs is expected to impede the growth of the multiple myeloma drugs market.

Top Company Profiles:
The major players operating in the multiple myeloma drugs market are Bristol-Myers Squibb, Celgene Corporation, Janssen Biotech, Inc., Novartis AG (Switzerland), Genzyme Corporation, Amgen, Inc., and Millennium Pharmaceuticals, amongst others.
Most of these companies are directing their efforts towards launching combination therapies for the treatment of multiple myeloma. Celgene is one of the leading players in the multiple myeloma drugs market. It has one drug in Phase III and five drugs is Phase II clinical trials for the treatment of relapsed/refractory multiple myeloma.

INFOGRAPICS Available for this Report in Special Discounted Price, Speak to Analyst and get more information
https://www.alltheresearch.com/speak-to-analyst/107

Recent News of Multiple Myeloma Drugs Market:
• In 2016, AbbVie and Bristol-Myers Squibb announced the EU approval of Empliciti™ (elotuzumab) for the treatment of adult multiple myeloma patients who have received at least one prior therapy. Empliciti™ (elotuzumab) has been approved for use in combination with dexamethasone and lenalidomide.
• In March 2018, Celgene Corporation completed the acquisition of Juno Therapeutics, Inc. This acquisition will position Celgene as a leading cellular immunotherapy company.
• In January 2019, Bristol-Myers Squibb has announced its plan to acquire Celgene Corporation for a whopping US$ 74 billion. The deal is expected to be completed by the third quarter of 2019.

Key questions answered:
• What is the value of the overall multiple myeloma drugs market and its segments?
• What is the value of the key segments and sub-segments in the multiple myeloma drugs market?
• Which are the attractive segments and geographies for investment?
• Who are the major players in the multiple myeloma drugs market and what are the key sustainable strategies of growth adopted by these players?
• What are the key unmet needs in major multiple myeloma drugs market?

View Complete Report with TOC, Tables and Figures:
https://www.alltheresearch.com/report/107/multiple-myeloma-drugs-market

Contact Info:
Name: Rohit B.
Email: Send Email
Organization: AllTheResearch
Address: 39180 LIBERTY STREET SUITE 110, FREMONT, CA 94538, USA
Phone: 8886916870
Website: https://www.alltheresearch.com

Source URL: https://marketersmedia.com/get-multiple-myeloma-drugs-market-infographics-2019-the-approval-of-new-drugs-to-drive-the-multiple-myeloma-drugs-market/516022

Source: MarketersMedia

Release ID: 516022

Related News

The Latest: Broncos' Bolles called for 4 holding penalties

Sep 17, 2019

The Latest on NFL Week 2 (all times EDT): 6:25 p.m. The most common call by official Adrian Hill: "Holding, No. 72." That would be Broncos left tackle Garett Bolles, who's been flagged four times for holding against Chicago. Each time his number was called, the boos from the crowd grew louder and louder. Bolles has now been flagged for various offenses 34 times in 34 career starts. He has five holding calls this season. — Pat Graham reporting in Denver. ___ 6 p.m. The Saints finally got a replay overturned in their favor against the Rams. However, it didn't...

Texans stop Jags' 2-point conversion to get 13-12 win

Sep 17, 2019

HOUSTON — Justin Reid didn't have to see the play again to know he'd kept Leonard Fournette out of the end zone on a 2-point conversion with seconds left that secured Houston's win over Jacksonville on Sunday. "I was 100% confident," he said. "I knew it on the field. I didn't need to see the replay. I knew it was a stop." Houston led by 7 in the fourth quarter when Jacksonville rookie Gardner Minshew led a long drive that included an 18-yard run on fourth-and-10, and he capped it with a 4-yard TD pass to DJ Chark. Instead of...

Lamar Jackson helps Ravens run past Cardinals 23-17

Sep 17, 2019

BALTIMORE — Lamar Jackson kept the Cardinals guessing all afternoon, supplementing an effective passing attack with more than an occasional jaunt out of the pocket. Arizona never could figure out what Baltimore's multifaceted star was going to do next. Jackson threw for 272 yards and two touchdowns, ran for 120 yards and helped the Ravens beat the Cardinals 23-17 Sunday in a showdown between two of the league's most exciting young quarterbacks. After achieving a perfect passer rating and throwing five TD passes in a season-opening 59-10 rout of Miami, Jackson wasn't quite as sharp through the air but far...

Pats' Antonio Brown said to be eligible, but will he play?

Sep 17, 2019

FOXBOROUGH, Mass. — Antonio Brown is said to be eligible to play against Miami. Whether he actually does after just three practices with the Patriots is still not clear. "We're determining that," coach Bill Belichick said Friday. "I'm not gonna hand out a copy of the game plan. We'll do what we think is best for the team." The star wide receiver Brown was not placed on the commissioner's exempt list, two people with direct knowledge of the decision told the Associated Press on Friday. They spoke on condition of anonymity because the decision has not been announced. Belichick, whose...

Bucs use goal-line stand to beat Panthers 20-14

Sep 17, 2019

CHARLOTTE, N.C. — When Cam Newton left the shotgun and began creeping toward the line of scrimmage, Buccaneers cornerback Vernon Hargreaves knew exactly what was coming. The Bucs sniffed out a fourth-and-1 play from the 2-yard line with Hargreaves shoving Christian McCaffrey out of bounds with 1:22 left to perverse a 20-14 win over the Carolina Panthers and cap off a terrific defensive performance on Thursday night. Jameis Winston threw for 208 yards and a touchdown, Chris Godwin had 121 yards receiving and a score and Peyton Barber ran for 82 yards, but it was the Bucs defense that won...

Broaden News

Replay Wall delivers the most accurate sports news to you with experts’ voice. We aim to bring every sports fan together here even if you’ve missed the game.

Contact us: sales@replaywall.com

Bowl Championship Series Professional Football Arena Football CFL Football NFL Football Youth Football Press Releases Broaden News